Titan Pharmaceuticals Inc
NASDAQ:TTNP

Watchlist Manager
Titan Pharmaceuticals Inc Logo
Titan Pharmaceuticals Inc
NASDAQ:TTNP
Watchlist
Price: 4.61 USD
Market Cap: 6.1m USD

Relative Value

TTNP doesn't have a meaningful market cap.

There is not enough data to reliably calculate the relative value of TTNP.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TTNP Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
5
Median 3Y
21.1
Median 5Y
6.6
Industry
2.6
vs History
vs Industry
Median 3Y
-1.1
Median 5Y
-1.2
Industry
21.7
vs History
vs Industry
Median 3Y
-1.1
Median 5Y
-1.4
Industry
16.7
vs History
vs Industry
Median 3Y
-1.1
Median 5Y
-1.3
Industry
23.1
vs History
33
vs Industry
47
Median 3Y
1.3
Median 5Y
1.9
Industry
2.2
vs History
vs Industry
14
Median 3Y
-2.4
Median 5Y
2.8
Industry
2.9
vs History
vs Industry
34
Median 3Y
0
Median 5Y
0
Industry
5.5
vs History
vs Industry
55
Median 3Y
-0.4
Median 5Y
-0.7
Industry
13.2
vs History
vs Industry
51
Median 3Y
-0.4
Median 5Y
-0.7
Industry
16.8
vs History
vs Industry
55
Median 3Y
-0.4
Median 5Y
-0.9
Industry
15.9
vs History
vs Industry
42
Median 3Y
-0.4
Median 5Y
-0.9
Industry
19.2
vs History
1
vs Industry
13
Median 3Y
9.9
Median 5Y
8.3
Industry
1.9

Multiples Across Competitors

TTNP Competitors Multiples
Titan Pharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Titan Pharmaceuticals Inc
NASDAQ:TTNP
6.1m USD 0 -1.3 -0.7 -0.7
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.2 55.7 37.4 40
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
492.4B USD 5.4 19.7 16 20.8
CH
Roche Holding AG
SIX:ROG
263.6B CHF 4.3 28 11.9 13.9
UK
AstraZeneca PLC
LSE:AZN
213.7B GBP 4.9 30.6 109.2 159.8
CH
Novartis AG
SIX:NOVN
212.5B CHF 4.8 18.6 11.8 15.3
US
Merck & Co Inc
NYSE:MRK
262.1B USD 4.1 13.7 9.8 11.6
DK
Novo Nordisk A/S
CSE:NOVO B
1.5T DKK 4.7 14.2 9.9 11.5
IE
Endo International PLC
LSE:0Y5F
209B USD 90.1 -71.5 331.1 830.4
US
Pfizer Inc
NYSE:PFE
143.3B USD 2.3 14.6 7.4 10.2
P/E Multiple
Earnings Growth PEG
US
Titan Pharmaceuticals Inc
NASDAQ:TTNP
Average P/E: 24.4
Negative Multiple: -1.3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
55.7
53%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.7
29%
0.7
CH
Roche Holding AG
SIX:ROG
28
29%
1
UK
AstraZeneca PLC
LSE:AZN
30.6
38%
0.8
CH
Novartis AG
SIX:NOVN
18.6
17%
1.1
US
Merck & Co Inc
NYSE:MRK
13.7
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
14.2
4%
3.5
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -71.5 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Titan Pharmaceuticals Inc
NASDAQ:TTNP
Average EV/EBITDA: 439.1
Negative Multiple: -0.7
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
37.4
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.9
4%
3
UK
AstraZeneca PLC
LSE:AZN
109.2
10%
10.9
CH
Novartis AG
SIX:NOVN
11.8
6%
2
US
Merck & Co Inc
NYSE:MRK
9.8
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.9
2%
5
IE
E
Endo International PLC
LSE:0Y5F
331.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
1%
7.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Titan Pharmaceuticals Inc
NASDAQ:TTNP
Average EV/EBIT: 1 881.6
Negative Multiple: -0.7
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
40
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
20.8
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.9
5%
2.8
UK
AstraZeneca PLC
LSE:AZN
159.8
23%
6.9
CH
Novartis AG
SIX:NOVN
15.3
12%
1.3
US
Merck & Co Inc
NYSE:MRK
11.6
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
11.5
1%
11.5
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
8%
1.3